These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25703523)

  • 21. Different orientations of low-molecular-weight fragments in the binding pocket of a BRD4 bromodomain.
    Lolli G; Battistutta R
    Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):2161-4. PubMed ID: 24100334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the chemical space of functionalized [1,2,4]triazolo[4,3-a]quinoxaline-based compounds targeting the bromodomain of BRD9.
    Gazzillo E; Pierri M; Colarusso E; Chini MG; Ferraro MG; Piccolo M; Irace C; Bruno I; Bifulco G; Terracciano S; Lauro G
    Bioorg Chem; 2023 Oct; 139():106677. PubMed ID: 37352721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails.
    Shen W; Xu C; Huang W; Zhang J; Carlson JE; Tu X; Wu J; Shi Y
    Biochemistry; 2007 Feb; 46(8):2100-10. PubMed ID: 17274598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disulfide bridge formation influences ligand recognition by the ATAD2 bromodomain.
    Gay JC; Eckenroth BE; Evans CM; Langini C; Carlson S; Lloyd JT; Caflisch A; Glass KC
    Proteins; 2019 Feb; 87(2):157-167. PubMed ID: 30520161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone cross-talk connects protein phosphatase 1α (PP1α) and histone deacetylase (HDAC) pathways to regulate the functional transition of bromodomain-containing 4 (BRD4) for inducible gene expression.
    Hu X; Lu X; Liu R; Ai N; Cao Z; Li Y; Liu J; Yu B; Liu K; Wang H; Zhou C; Wang Y; Han A; Ding F; Chen R
    J Biol Chem; 2014 Aug; 289(33):23154-23167. PubMed ID: 24939842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coordination of Di-Acetylated Histone Ligands by the ATAD2 Bromodomain.
    Evans CM; Phillips M; Malone KL; Tonelli M; Cornilescu G; Cornilescu C; Holton SJ; Gorjánácz M; Wang L; Carlson S; Gay JC; Nix JC; Demeler B; Markley JL; Glass KC
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor.
    Clark PG; Vieira LC; Tallant C; Fedorov O; Singleton DC; Rogers CM; Monteiro OP; Bennett JM; Baronio R; Müller S; Daniels DL; Méndez J; Knapp S; Brennan PE; Dixon DJ
    Angew Chem Int Ed Engl; 2015 May; 54(21):6217-21. PubMed ID: 25864491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains.
    Crawford TD; Tsui V; Flynn EM; Wang S; Taylor AM; Côté A; Audia JE; Beresini MH; Burdick DJ; Cummings R; Dakin LA; Duplessis M; Good AC; Hewitt MC; Huang HR; Jayaram H; Kiefer JR; Jiang Y; Murray J; Nasveschuk CG; Pardo E; Poy F; Romero FA; Tang Y; Wang J; Xu Z; Zawadzke LE; Zhu X; Albrecht BK; Magnuson SR; Bellon S; Cochran AG
    J Med Chem; 2016 Jun; 59(11):5391-402. PubMed ID: 27219867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.
    Poplawski A; Hu K; Lee W; Natesan S; Peng D; Carlson S; Shi X; Balaz S; Markley JL; Glass KC
    J Mol Biol; 2014 Apr; 426(8):1661-76. PubMed ID: 24333487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico design and molecular basis for the selectivity of Olinone toward the first over the second bromodomain of BRD4.
    Rodríguez Y; Gerona-Navarro G; Osman R; Zhou MM
    Proteins; 2020 Mar; 88(3):414-430. PubMed ID: 31587361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming.
    Sevinç K; Sevinç GG; Cavga AD; Philpott M; Kelekçi S; Can H; Cribbs AP; Yıldız AB; Yılmaz A; Ayar ES; Arabacı DH; Dunford JE; Ata D; Sigua LH; Qi J; Oppermann U; Onder TT
    Stem Cell Reports; 2022 Dec; 17(12):2629-2642. PubMed ID: 36332631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural basis and binding properties of the second bromodomain of Brd4 with acetylated histone tails.
    Liu Y; Wang X; Zhang J; Huang H; Ding B; Wu J; Shi Y
    Biochemistry; 2008 Jun; 47(24):6403-17. PubMed ID: 18500820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and Structure-Activity Relationships of Aristoyagonine Derivatives as Brd4 Bromodomain Inhibitors with X-ray Co-Crystal Research.
    Yoo M; Park TH; Yoo M; Kim Y; Lee JY; Lee KM; Ryu SE; Lee BI; Jung KY; Park CH
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33802888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site.
    Liu Z; Li Y; Chen H; Lai HT; Wang P; Wu SY; Wold EA; Leonard PG; Joseph S; Hu H; Chiang CM; Brasier AR; Tian B; Zhou J
    J Med Chem; 2022 Feb; 65(3):2388-2408. PubMed ID: 34982556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin.
    Devaiah BN; Case-Borden C; Gegonne A; Hsu CH; Chen Q; Meerzaman D; Dey A; Ozato K; Singer DS
    Nat Struct Mol Biol; 2016 Jun; 23(6):540-8. PubMed ID: 27159561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural ramification for acetyl-lysine recognition by the bromodomain of human BRG1 protein, a central ATPase of the SWI/SNF remodeling complex.
    Singh M; Popowicz GM; Krajewski M; Holak TA
    Chembiochem; 2007 Jul; 8(11):1308-16. PubMed ID: 17582821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Selective BRD9 Inhibitor via Integrated Computational Approach.
    Ali MM; Ashraf S; Nure-E-Alam M; Qureshi U; Khan KM; Ul-Haq Z
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors.
    Raj U; Kumar H; Varadwaj PK
    J Biomol Struct Dyn; 2017 Aug; 35(11):2351-2362. PubMed ID: 27494802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF.
    Li H; Ilin S; Wang W; Duncan EM; Wysocka J; Allis CD; Patel DJ
    Nature; 2006 Jul; 442(7098):91-5. PubMed ID: 16728978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9).
    Basuroy T; Dreier M; Baum C; Blomquist T; Trumbly R; Filipp FV; de la Serna IL
    Pigment Cell Melanoma Res; 2023 Jan; 36(1):19-32. PubMed ID: 36112085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.